logo
Share SHARE
FONT-SIZE Plus   Neg

EMA Validates Application For Bristol-Myers' Sprycel In Children With CML

Bristol-Myers Squibb Co. (BMY) said that the European Medicines Agency validated its grouped Type II variation/Extension of Application for Sprycel (dasatinib) to treat children and adolescents aged 1 year to 18 years with chronic phase Philadelphia chromosome positive chronic myelogenous leukemia or CML and to include the powder for oral suspension. Validation of the application confirms the submission is complete and begins the EMA's centralized review process.

The application includes data from CA180-226 (NCT00777036), an ongoing Phase 2, open-label, non-randomized trial studying Sprycel innewly diagnosed chronic phase CML pediatric patients and in pediatric patients resistant to or intolerant of imatinib. Data from this study will be presented at the American Society of Clinical Oncology Annual Meeting 2017 in Chicago on Monday, June 5.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Amazon.com may be talking with some middle-market pharmacy benefit managers or PBMs looking for various contractual arrangements, Axios reported, citing analysts at investment bank Leerink Partners. As per the report, the e-commerce giant, which recently entered the grocery industry with the purchase of Whole Foods for $13.4 billion, is eying to enter the pharmaceutical delivery business. Amazon.com Inc. is working on developing a pair of smart glasses that would allow to summon and interact with virtual assistant Alexa while wearing the device, the Financial Times reported, citing people familiar with the plans. The glasses, which would be required to be connected wirelessly to a smartphone to work, is reportedly designed to look like a regular pair of spectacles. Employees at Bombardier Inc.'s aerospace plant in Toronto plan to walk out of the facility on Wednesday morning. The move is an attempt to put pressure on Boeing Co. to drop a trade complaint against the Canadian plane and train maker.
comments powered by Disqus
Follow RTT